Ghusl

Geigy

Company type	Private
Industry	Pharmaceuticals
Founded	1758
Founder	Johann Rudolf Geigy-Gemuseus
Defunct	1996
Fate	Merged with Ciba to form Novartis

Geigy was a Swiss pharmaceutical company that played a significant role in the development of modern pharmaceuticals and chemicals. Founded in 1758 by Johann Rudolf Geigy-Gemuseus, the company initially focused on trading in "materials, chemicals, dyes, and drugs of all kinds." Over the centuries, Geigy evolved into a major player in the pharmaceutical industry, known for its innovative research and development.

History

The origins of Geigy can be traced back to the mid-18th century when Johann Rudolf Geigy-Gemuseus began trading in Basel, Switzerland. The company initially dealt in a variety of products, including dyes and chemicals, which were essential for the burgeoning textile industry in Europe.

In the 19th century, Geigy expanded its operations to include the production of synthetic dyes, which were in high demand due to the industrial revolution. This expansion laid the groundwork for the company's future ventures into pharmaceuticals.

Transition to Pharmaceuticals

In the early 20th century, Geigy began to focus more on pharmaceuticals, leveraging its expertise in chemistry and synthesis. The company invested heavily in research and development, leading to the discovery and commercialization of several important drugs.

One of Geigy's most notable contributions to medicine was the development of antihistamines, which are used to treat allergic reactions. The company's research in this area led to the creation of several widely used medications.

Merger and Legacy

In 1970, Geigy merged with another Swiss company, Ciba, to form Ciba-Geigy. This merger combined the strengths of both companies, creating a global leader in the pharmaceutical and chemical industries.

In 1996, Ciba-Geigy merged with Sandoz to form Novartis, one of the largest pharmaceutical companies in the world. The legacy of Geigy lives on through Novartis, which continues to be a leader in medical research and innovation.

Contributions to Medicine

Geigy's contributions to medicine are numerous and include the development of drugs for a variety of conditions. The company's research in antihistamines, for example, has had a lasting impact on the treatment of allergies and related conditions.

Geigy was also involved in the development of antimalarial drugs, which have been crucial in the fight against malaria, a disease that affects millions of people worldwide.

Also see

• Ciba-Geigy
• Novartis
• Pharmaceutical industry
• Antihistamines
• History of medicine